TREA

97978410 - ENTOS

Follow

Information

  • Trademark
  • 97978410
  • Serial Number
    97978410
  • Registration Number
    7568415
  • Filing Date
    September 14, 2022
    2 years ago
  • Registration Date
    November 19, 2024
    2 months ago
  • Transaction Date
    January 08, 2025
    15 days ago
  • Status Date
    November 19, 2024
    2 months ago
  • Published for Opposition Date
    September 03, 2024
    4 months ago
  • Location Date
    November 18, 2024
    2 months ago
  • First Use Anywhere Date
    April 01, 2011
    13 years ago
  • First Use In Commerce Date
    January 23, 2018
    7 years ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    HENRY, NAKIA
  • Attorney Docket Number
    079440.00003
    Attorney Name
    Theodore R. Remaklus
  • Owners
Information
Mark Drawing Code
3
Mark Identification
ENTOS
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
  • DM0000: The mark consists of the word "entos" and to the right three concentric rings of circles with the circles increasing in diameter from the inner ring to the outer ring.
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Medical therapy services, namely gene therapy services; medical analysis services, namely RNA or DNA analysis for virus diagnosis and prognosis; medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; on-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; genetic testing for medical purpose
  • GS0421: Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccines and medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific research purposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products; scientific research, pharmaceutical research, medical research, technical consultation in the field of pharmaceutical studies and product development for others in the field of biotechnology and product development of pharmaceuticals, therapeutic agents and medical devices; research and product development in the field of human vaccines, recombinant proteins and antibodies for therapeutic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Case File Event Statements
  • 9/17/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/29/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/30/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/27/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/27/2023 - a year ago
    8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 9/27/2023 - a year ago
    9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 11/16/2023 - a year ago
    14 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 6/26/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/27/2023 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/16/2023 - a year ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/27/2023 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/16/2023 - a year ago
    10 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 4/6/2024 - 9 months ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 6/12/2024 - 7 months ago
    13 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 6/25/2024 - 7 months ago
    15 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 7/25/2024 - 6 months ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/14/2024 - 5 months ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/3/2024 - 4 months ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/3/2024 - 4 months ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/19/2024 - 2 months ago
    20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/19/2024 - 2 months ago
    21 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 1/4/2025 - 19 days ago
    24 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/4/2025 - 19 days ago
    26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/4/2025 - 19 days ago
    22 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 1/4/2025 - 19 days ago
    25 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/4/2025 - 19 days ago
    27 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 1/4/2025 - 19 days ago
    23 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN